• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mem Inst Oswaldo Cruz . Low risk of serological cross-reactivity between dengue and COVID-19

tetano

Editor, Senior Moderator
Mem Inst Oswaldo Cruz


. 2020;115:e200225.
doi: 10.1590/0074-02760200225. Epub 2020 Aug 14.
Low risk of serological cross-reactivity between dengue and COVID-19


Michele Spinicci[SUP] 1 [/SUP], Alessandro Bartoloni[SUP] 1 [/SUP], Antonia Mantella[SUP] 1 [/SUP], Lorenzo Zammarchi[SUP] 1 [/SUP], Gian Maria Rossolini[SUP] 1 [/SUP], Alberto Antonelli[SUP] 1 [/SUP]



Affiliations

Abstract

In the near future, the overlap of Coronavirus disease 2019 (COVID-19) and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Among 32 COVID-19 positive sera, no positive Dengue virus (DENV) IgG/IgM results were observed. On the other hand, one false-positive result was observed among 44 DENV-positive sera tested for COVID-19 antibodies with each of the two rapid tests used. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.
 
Back
Top Bottom